The trial will last for 24 weeks, with researchers tracking "changes in drinking, health, and quality of life to determine whether the medication offers a meaningful new treatment option." RELATED: New GLP-1 drugs could suppress desire for more than just food, study suggests Currently, more than 400,000 veterans in the U.S
Rapid weight loss was one possible cause of the hair loss, the researchers explained
Daily subcutaneous dosing at 0.160.25mg is mandatory due to the 33-minute plasma half-life
GLP-1 users eating fewer calories are at higher risk for micronutrient deficiencies, particularly B12 , iron, zinc, magnesium, and vitamin D
Over time, oxidative stress, inflammation, and disease risk increase